Role of Reactive Oxygen Intermediates in TCR-Induced Death of T Cell Blasts and Hybridomas

Journal of Immunology

Volumn 157, Issue 6, 1996, Pages 2395-2402

  Williams, Mark S ^a   Henkart, Pierre A ^a,b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; FAS ANTIGEN; FAS LIGAND; FASL PROTEIN, MOUSE; FASLG PROTEIN, HUMAN; LIGAND; LYMPHOCYTE ANTIGEN RECEPTOR; MEMBRANE PROTEIN; OXYGEN; REACTIVE OXYGEN METABOLITE; THIOL DERIVATIVE;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL DEATH; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; HYBRIDOMA; LYMPHOCYTE ACTIVATION; METABOLISM; MOUSE; PHYSIOLOGY; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD95; ANTIOXIDANTS; CELL DEATH; FAS LIGAND PROTEIN; HUMANS; HYBRIDOMAS; LIGANDS; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MICE; OXYGEN; REACTIVE OXYGEN SPECIES; RECEPTORS, ANTIGEN, T-CELL; SULFHYDRYL COMPOUNDS; T-LYMPHOCYTES;

EID: 0030587124     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Schlegel, J., I. Peters, S. Orrenius, D. K. Miller, N. A. Thornberry, T. T. Yamin, and D. W. Nicholson. 1996. CPP32/apopain is a key interleukin-1-beta converting enzyme-like protease involved in Fas-mediated apoptosis. J. Biol. Chem. 271:1841.
2. Kumar, S., and N. L. Harvey. 1995. Role of multiple cellular proteases in the execution of programmed cell death. FEBS Lett. 375:169.
3. Nicholson, D. W., A. Ali, N. A. Thornberry, J. P. Vaillancourt, C. K. Ding, M. Gallant, Y. Gareau, P. R. Griffin, M. Labelle, Y. A. Lazebnik, N. A. Munday, S. M. Raju, M. E. Smulson, T.-T. Yamin, V. L. Yu, and D. K. Miller. 1995. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376:37.
4. Shi, L., W. K. Nishioka, J. Th'ng, E. M. Bradbury, D. W. Litchfield, and A. H. Greenberg. 1994. Premature p34cdc2 activation required for apoptosis. Science 263:1143.
5. Emoto, Y., Y. Manome, G. Meinhardt, H. Kisaki, S. Kharbanda, M. Robertson, T. Ghayur, W. W. Wong, R. Kamen, R. Weichselbaum, and D. Kufe. 1995. Proteolytic activation of protein kinase C zeta by an ICE-like protease in apoptotic cells. EMBO J. 14:6148.
6. Boise, L. H., A. R. Gottschalk, J. Quintans, and C. B. Thompson. 1995. Bcl-2 and Bcl-2-related proteins in apoptosis regulation. Contemp. Top. Mol. Immunol. 200: 107.
7. Cory, S. 1995. Regulation of lymphocyte survival by the BCL-2 gene family. Annu. Rer. Immunol. 13:513.
8. Korsmeyer, S. J. 1995. Regulators of cell death. Trends Genet. 11:101.
9. Kane, D. J., T. A. Sarafian, R. Anton, H. Hahn, E. B. Gralla, J. S. Valentine, T. Ord, and D. E. Bredesen. 1993. Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science 262:1274.
10. Buttke, T. M., and P. A. Sandstrom. 1994. Oxidative stress as a mediator of apoptosis. Immunol. Today 15:7.
11. Hockenbery, D. M., Z. N. Oltvai, X. M. Yin, C. L. Milliman, and S. J. Korsmeyer. 1993. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75:241.
12. Zhong, L. T., D. J. Kane, and D. E. Bredesen. 1993. BCL-2 blocks glutamate toxicity in neural cell lines. Brain Res. Mol. Brain Res. 19:353.
13. Ferrari, G., C. Y. I. Yan, and L. A. Greene. 1995. N-acetylcysteine (D- and L-stereoisomers) prevents apoptotic death of neuronal cells. J. Neurosci. 15: 2857.
14. Talley, A. K., S. Dewhurst, S. W. Perry, S. C. Dollard, S. Gummuluru, S. M. Fine, D. New, L. G. Epstein, H. E. Gendelman, and H. A. Gelbard. 1995. Tumor necrosis factor alpha-induced apoptosis in human neuronal cells: protection by the antioxidant N-acetylcysleine and the genes bcl-2 and crmA. Mol. Cell. Biol. 15:2359.
15. Goossens, V., J. Grooten, K. De Vos, and W. Fiers. 1995. Direct evidence for tumor necrosis factor-induced mitochondrial reactive oxygen intermediates and their involvement in cytotoxicity. Proc. Natl. Acad. Sci. USA 92:8115.
16. Jacobson, M. D., J. F. Burne, M. P. King, T. Miyashita, J. C. Reed, and M. C. Raff. 1993. Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA. Nature 361:365.
17. Muschel, R. J., E. J. Bernhard, L. Garza, W. G. McKenna, and C. J. Koch. 1995. Induction of apoptosis at different oxygen tensions: evidence that oxygen radicals do not mediate apoptotic signaling. Cancer Res. 55:995.
18. Jacobson, M. D., and M. C. Raff. 1995. Programmed cell death and Bcl-2 protection in very low oxygen. Nature 374:814.
19. Jones, D. P., E. Maellaro, S. Jiang, A. F. G. Slater, and S. Orrenius. 1995. Effects of N-acetyl-L-cysteine on T-cell apoptosis are not mediated by increased cellular glutathione. Immunol. Lett. 45:205.
20. Sandstrom, P. A., M. D. Mannie, and T. M. Buttke. 1994. Inhibition of activation-induced death in T cell hybridomas by thiol antioxidants: oxidative stress as a mediator of apoptosis. J. Leukocyte Biol. 55:221.
21. Nagata, S., and P. Golstein. 1995. The Fas death factor. Science 267:1449.
22. Lynch, D. H., F. Ramsdell, and M. R. Alderson. 1995. Fas and FasL in the homeostatic regulation of immune responses. Immunol. Today 16:569.
23. Russell, J. H. 1995. Activation-induced death of mature T cells in the regulation of immune responses. Curr. Opin. Immunol. 7:382.
24. Sarin, A., D. H. Adams, and P. A. Henkart. 1993. Protease inhibitors selectively block T-cell receptor-triggered programmed cell death in a murine T cell hybridoma and activated peripheral T cells. J. Exp. Med. 178:1693.
25. Clerici, M., A. Sarin, R. L. Coffman, T. A. Wynn, S. P. Blatt, C. W. Hendrix, S. F. Wolf, G. M. Shearer, and P. A. Henkart. 1994. Type 1/type 2 cytokine modulation of T cell programmed cell death as a model for HIV pathogenesis. Proc. Natl. Acad. Sci. USA 91:11811.
26. Alderson, M. R., T. W. Tough, S. Braddy, T. Davis-Smith, E. Roux, K. Schooley, R. E. Miller, and D. H. Lynch. 1994. Regulation of apoptosis and T cell activation by Fas-specific mAb. Int. Immunol. 6:1799.
27. Bryant, J., R. Day, T. L. Whiteside, and R. B. Herberman. 1992. Calculation of lytic units for the expression of cell-mediated cytotoxicity. J. Immunol. Methods 146:91.
28. Mercep, M., P. D. Noguchi, and J. D. Ashwell. 1989. The cell cycle block and lysis of an activated T cell hybridoma are distinct processes with different Ca2+ requirements and sensitivity to cyclosporine A. J. Immunol. 142:4085.
29. Hug, H., M. Enari, and S. Nagata. 1994. No requirement of reactive oxygen intermediates in Fas-mediated apoptosis. FEBS Lett. 351:311.
30. Schulze-Osthoff, K., P. H. Krammer, and W. Droge. 1994. Divergent signalling via APO-1/Fas and the TNF receptor, two homologous molecules involved in physiological cell death. EMBO J. 13:4587.
31. Dornand, J., C. Sekkat, J. C. Mani, and M. Gerber. 1987. Lipoxygenase inhibitors suppress IL-2 synthesis: relationship with rise of [Ca++]i and the events dependent on protein kinase C activation. Immunol. Lett. 16:101.
32. Dornand, J., and M. Gerber. 1989. Inhibition of murine T-cell responses by antioxidants: the targets of lipo-oxygenase pathway inhibitors. Immunology 68:384.
33. Aussel, C., J. P. Breittmayer, M. Ticchioni, C. Pelassy, and A. Bernard. 1994. Regulation of T cell activation by cytochrome P450 inhibitors. Cell Immunol. 155:436.
34. McConkey, D. J., M. Jondal, and S. Orrenius. 1992. Cellular signalling in thymocyte apoptosis. Semin. Immunol. 4:371.
35. Cohen, J. J., and R. C. Duke. 1984. Glucocorticoid activation of a calcium dependent endonuclease in thymocyte nuclei leads to cell death. J. Immunol. 132: 38.
36. Squier, M. K. T., A. C. K. Miller, A. M. Malkinson, and J. J. Cohen. 1994. Calpain activation in apoptosis. J. Cell. Physiol. 159:229.
37. Zacharchuk, C. M., M. Mercep, P. K. Chakraborti, S. S. Simons, Jr., and J. D. Ashwell. 1990. Programmed T lymphocyte death: cell activation- and steroid-induced pathways are mutually antagonistic. J. Immunol. 145:4037.
38. Alderson, M. R., T. W. Tough, T. Davis-Smith, S. Braddy, B. Falk, K. A. Schooley, R. G. Goodwin, C. A. Smith, F. Ramsdell, and D. H. Lynch. 1995. Fas ligand mediates activation-induced cell death in human T lymphocytes. J. Exp. Med. 181:71.
39. Schulze-Osthoff, K., M. Los, and P. A. Baeuerle. 1995. Redox signalling by transcription factors NF-kappa B and AP-1 in lymphocytes. Biochem. Pharmacol. 50:735.
40. Suda, T., T. Takahashi, P. Golstein, and S. Nagata. 1993. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 78:1169.
41. Takahashi, T., M. Tanaka, J. Inazawa, T. Abe, T. Suda, and S. Nagata. 1994. Human Fas ligand: gene structure, chromosomal location and species specificity. Int. Immunol. 6:1567.
42. Ivanov, V. N., G. Deng, E. R. Podack, and T. R. Malek. 1995. Pleiotropic effects of Bcl-2 on transcription factors in T cells: potential role of NF-kB p50-p50 for the anti-apoptotic function of Bcl-2. Int. Immunol. 7:1709.
43. 2 and antioxidants have opposite effects on activation of NF-kappa B and AP-1 in intact cells. AP-I as secondary antioxidant-responsive factor. EMBO J. 12:2005.
44. Abate, C., L. Patel, F. J. Rauscher, III, and T. Curran. 1990. Redox regulation of fos and jun DNA-binding activity in vitro. Science 249:1157.
45. Coyle, J. T., and P. Puttfarcken. 1993. Oxidative stress, glutamate, and neurodegenerative disorders. Science 262:689.
46. Caner, H., J. L. Collins, S. M. Harris, N. F. Kassell, and K. S. Lee. 1993. Attenuation of AMPA-induced neurotoxicity by a calpain inhibitor. Brain Res. 607: 354.
47. Los, M., H. Schenk, K. Hexel, P. A. Baeuerle, W. Droge, and K. Schulze-Osthoff. 1995. IL-2 gene expression and NF-κB activation through CD28 requires reactive oxygen production by 5-lipoxygenase. EMBO J. 14:3731.
48. Weitzel, F., and A. Wendel. 1996. Selenoenzymes regulate the activity of leukocyte 5-lipoxygenase via the peroxide tone. J. Biol. Chem. 268:6288.
49. Jakobsson, P.-J., P. Larsson, S. Feltenmark, B. Odlander, G. Runarsson, M. Bjorkholm, and H.-E. Claesson. 1996. The 5-lipoxygenase pathway in normal and malignant human B lymphocytes. Adv. Prostaglandin Thromboxane Leukotriene Res. 23:293.